Stanford University
Showing 14,701-14,750 of 36,203 Results
-
Maximilian Julve
Clinical Assistant Professor, Medicine - Oncology
BioDr. Max Julve is a medical oncologist and Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine, with a clinical and research focus in solid tumor cellular therapy and melanoma.
Dr. Julve completed his medical training at Barts and The Royal London School of Medicine in the United Kingdom, followed by internal medicine training at teaching hospitals across North and Central London. He was subsequently awarded a National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship in Medical Oncology at Imperial College London. During this time, alongside his clinical training, he conducted translational research within the King’s College London Immunoengineering group, focusing on transcriptional optimization of CAR-T cell therapies.
Dr. Julve later completed advanced clinical fellowships in solid tumor cellular therapy and melanoma at The Royal Marsden Hospital, London, and earned an MD(Res) doctorate investigating the role of immunosuppressive granulocytes in patients receiving immunotherapy.
He is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor cellular therapy, with a particular emphasis on translating mechanistic insights from the laboratory into novel therapeutic strategies for patients. -
Patrick Jurney
Affiliate, Chemical and Systems Biology Operations
Visiting Scholar, Chemical and Systems Biology OperationsBioPatrick Jurney is the Kordestani Endowed Chair and an Associate Professor of Biomedical Engineering at San Jose State University. A Fellow of the American Heart Association (FAHA), his research focuses on the intersection of fluid dynamics and cellular mechanics, with a particular emphasis on cardiovascular health and disease..
Dr. Jurney completed his Ph.D. in Thermal Fluid Systems at the University of Texas at Austin, where he designed and built microphysiological systems to investigate the role of nanoparticle properties in targeted drug delivery. Following his doctoral studies, he was a T-32 Fellow in Translational Engineering at Oregon Health & Science University (OHSU). During his fellowship, he worked with cardiovascular biomaterials and characterized how biomaterial properties influence endothelialization and thrombogenesis.
Currently, his research laboratory at SJSU investigates the role of fluid shear stress mechanotransduction on endothelial metabolic structure and function. Dr. Jurney is a pioneer in using holotomographic microscopy to study sub-cellular organelles in cardiovascular disease. He is also collaborating in the laboratory of Dr. Daria Mochly-Rosen to characterize the role of mitochondrial structure and dynamics in metabolic function in response to ischemia/reperfusion and other models of cardiovascular health and disease.
Website: https://www.jurneylab.org/
Email: patrick.jurney@sjsu.edu or pjurney@stanford.edu
